Agios Pharmaceuticals chief commercial officer joins Ignyta board
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Ignyta Inc. added Agios Pharmaceuticals Chief Commercial Officer Steven Hoerter to its board as an independent director.
Hoerter will also be a member of the nominating and corporate governance committee. He previously served as executive vice president and chief commercial officer at Clovis Oncology Inc.
His appointment expands Ignyta's board to six members from five.
